AllianceBernstein
CUE icon

AllianceBernstein’s Cue Biopharma CUE Stock Holding History

AllianceBernstein’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,117
Closed -$163K – 3289
2022
Q1 		$163K Buy
1,117
+4
+0.4% +$848 ﹤0.01% 3034
2021
Q4 		$378K Hold
1,113
– – ﹤0.01% 2859
2021
Q3 		$487K Hold
1,113
– – ﹤0.01% 2769
2021
Q2 		$389K Buy
1,113
+160
+17% +$62K ﹤0.01% 2916
2021
Q1 		$349K Sell
953
-110
-10% -$45.3K ﹤0.01% 2840
2020
Q4 		$399K Hold
1,063
– – ﹤0.01% 2701
2020
Q3 		$480K Sell
1,063
-124
-10% -$71.5K ﹤0.01% 2549
2020
Q2 		$873K Buy
1,187
+747
+170% +$541K ﹤0.01% 2274
2020
Q1 		$187K Buy
+440
New +$213K ﹤0.01% 2817

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AllianceBernstein's CUE Position: Q2 2022 in Review

AllianceBernstein sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 1,117 shares — an estimated $163K sold.

AllianceBernstein first reported a position in CUE in Q1 2020 and held it in 9 quarters. The position peaked at $873K in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • AllianceBernstein reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 1,117 Cue Biopharma shares in Q2 2022, an estimated $163K.
  • AllianceBernstein first reported a position in Cue Biopharma in Q1 2020 and held it in 9 quarters.
  • AllianceBernstein's Cue Biopharma position peaked at $873K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.